Correlation Between JPMorgan Chase and Pfizer

Can any of the company-specific risk be diversified away by investing in both JPMorgan Chase and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining JPMorgan Chase and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between JPMorgan Chase Co and Pfizer Inc, you can compare the effects of market volatilities on JPMorgan Chase and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in JPMorgan Chase with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of JPMorgan Chase and Pfizer.

Diversification Opportunities for JPMorgan Chase and Pfizer

-0.09

Correlation Coefficient

JPMorgan Chase  Pfizer

Good diversification

The 3 months correlation between JPMorgan and Pfizer is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding JPMorgan Chase Co and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and JPMorgan Chase is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on JPMorgan Chase Co are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of JPMorgan Chase i.e., JPMorgan Chase and Pfizer go up and down completely randomly.

Pair Corralation between JPMorgan Chase and Pfizer

Considering the 90-day investment horizon JPMorgan Chase Co is expected to generate 0.99 times more return on investment than Pfizer. However, JPMorgan Chase Co is 1.01 times less risky than Pfizer. It trades about 0.08 of its potential returns per unit of risk. Pfizer Inc is currently generating about -0.06 per unit of risk. If you would invest  11,681  in JPMorgan Chase Co on January 25, 2024 and sell it today you would earn a total of  7,575  from holding JPMorgan Chase Co or generate 64.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

JPMorgan Chase Co  vs.  Pfizer Inc

JPMorgan Chase

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in JPMorgan Chase Co are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, JPMorgan Chase may actually be approaching a critical reversion point that can send shares even higher in May 2024.

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with JPMorgan Chase and Pfizer

The main advantage of trading using opposite JPMorgan Chase and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if JPMorgan Chase position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.

The idea behind JPMorgan Chase Co and Pfizer Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.